Berlin Initiative Study
- Conditions
- N18Acute myocardial infarctionI21Chronic kidney disease
- Registration Number
- DRKS00017058
- Lead Sponsor
- KfH-Stiftung Präventivmedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 2069
Inclusion Criteria
>=70 years,
membership in statutory insurance company (AOK Nordost),
level of care III
Exclusion Criteria
<70 years
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiovascular events such as stroke and myocardial infarction,<br>Death, dialysis
- Secondary Outcome Measures
Name Time Method Hospitalization,<br><br>level of care
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link chronic kidney disease (N18) and acute myocardial infarction (I21) in DRKS00017058 observational study?
How does DRKS00017058 compare standard-of-care outcomes for patients with comorbid N18 and I21?
Which biomarkers in DRKS00017058 identify high-risk patients with both chronic kidney disease (N18) and acute myocardial infarction (I21)?
What adverse event profiles are observed in DRKS00017058 for patients with comorbid N18 and I21 under standard therapies?
Are there novel therapeutic targets or combinations for managing N18 and I21 comorbidity based on DRKS00017058 findings?